These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2134630)

  • 1. Treatment options for the fetus with alloimmune hemolytic disease.
    Bowman JM
    Transfus Med Rev; 1990 Jul; 4(3):191-207. PubMed ID: 2134630
    [No Abstract]   [Full Text] [Related]  

  • 2. Oliver memorial lecture. Towards the conquest of Rh haemolytic disease: Britain's contribution and the role of serendipity.
    Tovey LA
    Transfus Med; 1992 Jun; 2(2):99-109. PubMed ID: 1339195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis and perinatal outcome after intravascular transfusion].
    Monico-Ramos R; Ochoa-Flores M; Hernández-Herrera RJ; Flores-Pompa E
    Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of intraperitoneal transfusion under direct ultrasound guidance].
    De la Luna y Olsen E; Amézcua Llauger LE; Leis Marquez MT; Sánchez Solis V
    Ginecol Obstet Mex; 1991 Apr; 59():128-33. PubMed ID: 1908814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
    Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
    Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal CW alloimmunization.
    Bowman JM; Pollock J
    Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease.
    Berlin G; Selbing A; Gottvall T
    Prog Clin Biol Res; 1990; 337():337-40. PubMed ID: 2112753
    [No Abstract]   [Full Text] [Related]  

  • 10. Allo-immunization during pregnancy. Clinical results from 1983 to 1989 in a Scandinavian university hospital.
    Belfrage P; Thomassen P; Floberg J; Akerblom O; Broberger U
    Acta Obstet Gynecol Scand; 1992 May; 71(4):273-7. PubMed ID: 1322620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of hemolytic disease in the fetus and newborn.
    Bowman J
    Semin Perinatol; 1997 Feb; 21(1):39-44. PubMed ID: 9190032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immune globulin in the management of severe Rh D hemolytic disease.
    Porter TF; Silver RM; Jackson GM; Branch DW; Scott JR
    Obstet Gynecol Surv; 1997 Mar; 52(3):193-7. PubMed ID: 9061721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
    Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
    Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of erythroblastosis in the fetus.
    Liley AW
    Adv Pediatr; 1968; 15():29-63. PubMed ID: 4966222
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
    Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
    Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation.
    Westgren M; Selbing A; Stangenberg M
    Br Med J (Clin Res Ed); 1988 Mar; 296(6626):885-6. PubMed ID: 3129060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern diagnosis and therapy of fetomaternal blood group incompatibility].
    Vetter K; Favre Y
    Arch Gynecol Obstet; 1990; 247 Suppl():S25-35. PubMed ID: 2128174
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 20. Rh haemolytic disease: continuing problem of management.
    Swinhoe DJ; Gilmore DH; McNay MB; Whittle MJ
    Arch Dis Child; 1990 Apr; 65(4 Spec No):365-8. PubMed ID: 2110805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.